OBIO

NASDAQStock

Orchestra BioMed Holdings, Inc.

$4.21-0.17 (-3.77%)

52-Week Range

$2.35
$5.35

Key Stats

Market Cap

P/E Ratio

Dividend Yield

Beta

0.59

Volume

245.4K

Avg Volume

246.7K

Performance

1M

+14.66%

3M

+1.86%

6M

+68.46%

YTD

+1.62%

1Y

+7.35%

3Y

-65.35%

5Y

-51.17%

Price Chart

ETF Exposure

OBIO is held by 15 ETFs

ETFFund NameWeight
SURISimplify Propel Opportunities ETF1.40%
IWCiShares Micro-Cap ETF0.04%
IBBQInvesco Nasdaq Biotechnology ETF0.02%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.02%
BIBProShares - Ultra Nasdaq Biotechnology0.01%
SCHASchwab U.S. Small-Cap ETF0.00%
VXFVanguard Extended Market ETF0.00%
AVSCAvantis U.S. Small Cap Equity ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About OBIO ETF Exposure

Orchestra BioMed Holdings, Inc. (OBIO) is held by 15 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $4.21. Investors can gain exposure to OBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold OBIO, sorted by portfolio weight.